The arrival of Omicron has pushed daily caseloads to their highest levels and sent a stream of new coronavirus-positive people to the hospital.
L.A. County recorded 45,584 new cases amid the surge in infections driven by the highly contagious Omicron variant, according to figures released Sunday.
But even those who have been admitted to hospitals for other reasons place a high burden on the healthcare facilities, according to L.A. County Public Health Director Barbara Ferrer. During last winter’s COVID-19 surge, about 80% of coronavirus-positive patients in the emergency department at L.A. County-USC Medical Center were being admitted, and nearly half of those went to the intensive care unit, according to Dr. Brad Spellberg, the hospital’s chief medical officer. Now, about a third of coronavirus-positive patients are admitted, and 20% to 25% are going to the ICU.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stay home or go to work sick? Workers face difficult choice in time of COVID-19′s omicron surgeMillions of workers whose jobs don’t provide paid sick days are having to choose between their health and their paycheck as the omicron variant of COVID-19 surges.
Read more »
Stay Home Or Work Sick? Omicron Poses a ConundrumMillions of workers whose jobs don’t provide paid sick days are having to choose between their health and their paycheck as the omicron variant of COVID-19 rages across the nation.
Read more »
COVID sick time: Stay home or work? Omicron poses conundrumMillions of workers whose jobs don’t provide paid sick days are having to choose between their health and their paycheck as the omicron variant of COVID-19 rages across the nation.
Read more »
COVID sick time: Stay home or work? Omicron poses conundrumMillions of workers whose jobs don’t provide paid sick days are having to choose between their health and their paycheck as the omicron variant of COVID-19 rages across the nation.
Read more »
COVID-19 symptoms and the Omicron variant: What the latest studies showSome distinctive COVID-19 symptoms, like loss of taste and smell, now appear to be less common.
Read more »
Avacta pauses sales of COVID-19 antigen test to boost Omicron sensitivityBritish biotech firm Avacta Group said on Monday it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron coronavirus variant at lower viral loads.
Read more »